Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10304176 | Psychiatry Research | 2015 | 5 Pages |
Abstract
Recent findings support the role of purinergic system dysfunction in the pathophysiology of bipolar disorder (BD). The present study aimed to evaluate the pattern of serum uric acid levels in a sample of 98 BD I patients followed-up prospectively in a naturalistic study and treated with lithium monotherapy or in association with other mood stabilizers (valproate or carbamazepine), in relation to different phases of illness and to pharmacological treatment. The results showed that uric acid levels were significantly higher in patients suffering from a manic/mixed episode, than in those euthymic or during a depressive phase. Further, these levels were related to the Clinical Global Impression-Bipolar Version (CGI-BP) scale score for the severity of manic symptoms. A positive correlation was found also with male sex and with serum lithium levels. These findings suggest that a dysregulation of the purinergic system may occur during manic/mixed episodes, and they support a possible role of serum uric acid levels as a state-dependent marker of BD manic phases.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Matteo Muti, Claudia Del Grande, Laura Musetti, Donatella Marazziti, Milo Turri, Marco Cirronis, Irene Pergentini, Martina Corsi, Liliana Dell'Osso, Giovanni Umberto Corsini,